Ilyang Pharmaceutical’s new ‘ER—GMP level’ factory for Supect

Published: 2015-11-04 15:02:54

Updated: 2015-11-04 15:02:54

Ilyang Pharmaceutical(CEO Dong-yeon Kim) had a ceremony for completion of a manufacturing facility exclusively for “Supect,” a chronic myeloid leukemia, at the BioValley located in Jecheon-si, Chungcheongbuk-do, at 10am on Nov. 2.

The “Supect’ manufacturing facility, whose construction was started on November 2014 and finished approximately in a year, is a 2-storey building on the total 1,140m...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.